Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV epidemiology research study

Journal of the American Medical Association

Volumn 285, Issue 11, 2001, Pages 1466-1474

  Ickovics, Jeannette R ^a   Hamburger, Merle E ^b   Vlahov, David ^c   Schoenbaum, Ellie E ^d   Schuman, Paula ^e   Boland, Robert J ^f   Moore, Janet ^b  

^a YALE UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DEMOGRAPHY; DEPRESSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; SELF REPORT; SEX RATIO; UNITED STATES; UNIVERSITY HOSPITAL; VIRUS LOAD;

EID: 0035925774     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.11.1466     Document Type: Article

References (69)

1. Depression and mortality in nursing homes
2. Mechanisms of disease: Neuroendocrine-immune interactions
3. Association between depression and mortality in older adults
4. Depression and immunity: A meta-analytical review
5. Health psychology: Psychological factors and physical disease from perspectives of human psychoneuroimmunity
6. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey
7. Depressive effect and survival among gay and bisexual men infected with HIV
8. Progression to AIDs: The effects of stress, depressive symptoms, and social support
9. Relationship of psychosocial factors to HIV disease progression
10. Depressive symptoms as predictors of medical outcomes in HIV infection
11. Relation of stressors and depressive symptoms to clinical progression of viral illness
12. Psychological and behavioral issues of a cohort of Puerto Rican HIV/AIDS patients
13. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men
14. Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men
15. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men: A 2-year follow-up study
16. HIV and depression
17. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus
18. Psychopathology in male and female intravenous drug users with and without HIV infection
19. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men
20. Mood disorders in HIV infection
21. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America
22. The design, participants, and selected early findings of the HIV Epidemiology Research Study
23. Distress and coping among women with HIV infection
24. Psychopathology in male and female HIV-positive and negative injecting drug users
25. Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS
26. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection
27. Psychiatric diagnosis before serological testing for the human immunodeficiency virus
28. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus
29. Social and psychological characteristics of HIV-infected women and gay men
30. Women and AIDS: A contextual analysis
31. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study
32. Quality control in the flow cytometric measurement of T-lymphocyte subsets
33. The CES-D scale: A self-report depression scale for research in the general population
34. Use of self-report symptom scale to detect depression in a community sample
35. The Center for Epidemiologic Studies Depression Scale: Its use in a community sample
36. Presence and persistence of depressive symptoms in patients and community populations
37. Rates of symptoms of depression in a national sample
38. Minority status and psychological distress reexamined: The case of Mexican Americans
39. Depressive symptoms, major depression, and generalized anxiety: A comparison of self-reports on CES-D and results from diagnostic interviews
40. Depressive disorders
41. Assessing persons with HIV infection using the Beck Depression Inventory
42. Stability of mood despite HIV illness progression in a group of homosexual men
43. Psychiatric status and nine-year mortality data in the New Haven Epidemiologic Catchment Area Study
44. Depression and 18-month prognosis after myocardial infarction
45. Depression following myocardial infarction: Impact on 6-month survival
46. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical conditions
47. Major depression and all-cause mortality among white adults
48. A systematic review of the mortality of depression
49. Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men
50. Pathways linking major depression and immunity in ambulatory female patients
51. Protective and damaging effects of stress mediators
52. Treatment of major depression in HIV-seropositive men
53. Prescription of and adherence to antiretroviral therapy among women with AIDS
54. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
55. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
56. Viral dynamics of HIV: Implications for drug development and therapeutic strategies
57. Variations in the care of HIV-infected adults in the United States
58. Depressive symptoms decline among persons on HIV protease inhibitors
59. Depression and HIV: How does one affect the other?
60. Violence among women with or at risk for HIV infection
61. Women and AIDS: A contextual approach
62. Treatment of depressive symptoms in HIV-positive patients
63. Randomized, placebo-controlled trial of paroxetine vs. imipramine in depressed HIV-positive outpatients
64. Treating depression in HIV-positive patients
65. Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression
66. Antidepressant treatment of depression in HIV-seropositive women
67. Fluoxetine treatment for depression in patients with HIV and AIDS